Pricing Log in Create free account
Saturday 17 October 2026 Export MODVQ’s income statement to Excel — free account

ModivCare Inc.

MODVQ Healthcare Medical Care Facilities

ModivCare Inc.’s revenue for fiscal 2024 (year ended December 2024) was $2.8 billion, up 1.32% from fiscal 2023. In the quarter to September 2025, revenue fell 3.18%, EPS fell 171.7% and free cash flow fell 3,767.7%, each against the same quarter a year earlier. Revenue growth for five consecutive years.

0.02 0.00 0.00%
Market cap
$6.2M
P/E
0.0×
Fwd P/E
0.0×
Dividend yield
—
F-score
3/9
Altman Z
1.28
Beneish M
−3.11
Dividend safety
n/a
Overview Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Insider Decisions trades per month

Dec 25 Mar 26 Jun 26 Sep 26
Buy — — — — — — — — — — — —
Sell — — — — — — — — — — — —
Insider Ownership 16.81%

Capital & Financial Ratios $m

Market Cap 6.20
Revenue 2,692.71
Net Income (450.69)
Free Cash Flow (146.99)
Net Debt (66.76)
Current Ratio 1.64 (at or above 1.5: strong)
Debt/Equity (0.13) (negative: negative equity)
P/E ratio 0.00
Fwd P/E (0.04) (negative: loss-making)
P/S ratio 0.00
P/B ratio 0.00
Past 5Y EPS Growth —
This Y EPS Growth (902.37%) (below 0%: weak)
Next Y EPS Growth 23.04% (at or above 15%: strong)
Next Y revenue growth (5.01%) (below 0%: weak)
Next 5Y EPS Growth 18.36% (at or above 15%: strong)

Green and red mark values outside typical ranges. How we judge →

Valuation vs history

EV/Sales, ten years
EV/Sales is 0.4×, against a ten-year median of 0.6×; over the ten years it ranged from 0.4× in 2025 to 1.9× in 2021.

Dividends

Payout Ratio —
Annual Dividend Rate —
Annual Dividend Yield —
total individual payouts
2025 Powerpack
2024 Powerpack
2023 Powerpack
2022 Powerpack
2021 Powerpack
2020 1.37
1.37
2019 Powerpack
2017 Powerpack
predictions special payouts not included in total or ratios

Assets vs Liabilities $m

2022 2023 2024 Q'25
Cash 15 3 113 129
Receivables 297 375 357 415
Inventory — — — —
Other — — — —
346 405 495 587
2022 2023 2024 Q'25
Payables 55 55 83 89
ST’ Debt 10 114 274 63
Other — — — —
492 520 624 358

Compound Annual Growth %

10y 5y 3y
Sales 9.82% 13.05% 11.76%
Cash Flow 0.00% 0.00% 0.00%
Earnings 0.00% 0.00% 0.00%
Book Value 0.00% 0.00% 0.00%

Revenue $m

Mar Jun Sep Dec Year
’26 651 660 680 — —
’24 684 698 702 703 2,788
’23 664 702 687 698 2,751
’22 575 632 649 649 2,504
’21 456 474 493 573 1,997
’20 367 282 321 399 1,369
’19 368 364 393 385 1,510
Fiscal quarters ending in the months shown.

Operating Cash Flow $m

Mar Jun Sep Dec Year
’26 (82) (22) (50) — —
’24 10 (55) 9 30 (6)
’23 (3) (108) 54 (26) (83)
’22 71 (20) (6) (56) (10)
’21 135 35 6 12 187
’20 39 108 140 61 348
’19 39 (16) 17 21 61
Fiscal quarters ending in the months shown.

Free Cash Flow $m

Mar Jun Sep Dec Year
’26 (86) (29) (57) — —
’24 2 (62) 2 25 (34)
’23 (16) (117) 45 (37) (125)
’22 63 (28) (15) (63) (43)
’21 129 32 0 5 166
’20 37 108 138 54 336
’19 37 (18) 14 17 50
Fiscal quarters ending in the months shown.

EPS $

Mar Jun Sep Dec Year
’26 (3.52) (21.16) (5.08) — —
’24 (1.57) (9.07) (1.87) (1.64) (14.14)
’23 (0.28) (13.47) (0.30) (0.37) (14.43)
’22 0.02 0.24 (2.03) (0.49) (2.26)
’21 1.31 0.96 (0.54) (2.25) (0.47)
’20 1.00 (0.98) 2.50 (0.22) 2.37
’19 (0.04) (0.22) 0.47 (0.55) (0.26)
Fiscal quarters ending in the months shown.

Target Price Range

Analyst price targets

Recommendation Rating

3
1Buy 2 3Hold 4 5Sell

Ten years at a glance Fiscal years to December

Group Line 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 Trend 2025e 2026e 2027e
Price, $
Price, $ Low — 34.89 35.65 55.17 46.53 40.40 121.00 73.06 26.05 10.20

Analyst estimates 2025–2027

Powerpack
High — 55.28 60.95 83.90 74.73 147.32 211.94 148.46 113.53 52.33
People
People Employees — 7,620 7,100 4,000 3,800 17,500 20,200 20,000 21,200 23,675
Revenue/emp, $m — 0.16 0.19 0.35 0.40 0.08 0.10 0.13 0.13 0.12
Income, $m
Income, $m Revenue — 1,234 1,318 1,385 1,510 1,369 1,997 2,504 2,751 2,788
Gross margin, % — 8.26 9.18 9.48 7.21 21.18 20.66 18.86 16.25 15.08
EBT — 45 55 23 24 104 40 (5) (209) (199)
EBT margin, % — 3.64 4.18 1.65 1.60 7.63 2.02 (0.19) (7.60) (7.13)
Net income — 90 54 (19) 1 89 (7) (32) (204) (201)
Depreciation — 49 27 28 17 27 60 106 293 221
Per share, $
Per share, $ Revenue — 84.12 96.91 106.86 116.52 100.88 142.09 178.10 194.10 195.76
Earnings — 5.07 3.08 (1.95) (0.26) 2.39 (0.47) (2.26) (14.43) (14.14)
Cash flow — 2.85 4.05 0.61 4.70 25.68 13.29 (0.74) (5.85) (0.45)
Capex — (2.74) (1.46) (1.35) (0.84) (0.90) (1.52) (2.35) (2.98) (1.94)
Free cash flow — 0.11 2.58 (0.74) 3.86 24.79 11.78 (3.09) (8.84) (2.39)
Book value — 25.58 24.70 23.99 24.51 30.34 26.56 25.21 11.02 (2.70)
Shares, m — 15 14 13 13 14 14 14 14 14
Valuation, ×
Valuation, × P/E — 7.45 19.48 0.00 0.00 59.75 0.00 0.00 0.00 0.00
P/S — 0.46 0.62 0.56 0.51 1.37 1.04 0.52 0.23 0.06
P/B — 1.89 2.44 2.50 2.41 4.57 5.58 3.65 4.03 0.00
EV/Sales — 0.40 0.58 0.56 0.48 1.60 1.47 0.91 0.63 0.47
EV/FCF — 309.15 21.86 (80.22) 14.39 6.52 17.74 (52.20) (13.77) (38.67)
Cash, $m
Cash, $m Operating cash flow — 42 55 8 61 348 187 (10) (83) (6)
Capex — (40) (20) (18) (11) (12) (21) (33) (42) (28)
Free cash flow — 2 35 (10) 50 336 166 (43) (125) (34)
Balance, $m
Balance, $m Working capital — 60 69 68 106 102 (117) (145) (115) (129)
Total debt — 4 3 1 15 494 985 989 1,098 1,261
Net debt — (72) (51) (6) (46) 311 852 974 1,095 1,148
Shareholders’ equity — 375 336 311 318 412 373 355 156 (38)
Returns, %
Returns, % ROA — 8.87 6.14 (3.97) (0.59) 3.21 (0.38) (1.60) (11.02) (11.77)
ROIC — 9.92 8.22 4.98 5.70 10.56 4.56 2.68 (6.99) (5.23)
ROE — 26.18 13.46 (7.81) (1.09) 8.91 (1.68) (8.74) (80.06) (341.96)
Negative figures in brackets.

All 10 years →

Fiscal years to Dec 2024 · latest quarter Sep 2025

Charts ten years each

ModivCare Inc. vs peers in Medical Care Facilities (Q) = latest quarter vs a year earlier

Company Market cap P/E Fwd P/E Revenue growth (Q) EPS growth (Q) FCF growth (Q) Gross margin (Q) EBIT margin (Q) Compare
DCGO DocGo Inc. $27.9M — (loss-making) — (loss-making) −8.70% (below 0%: shrinking) n/m −132.28% (below 0%: shrinking) 30.52% (24.41%) Compare
PAIYY Aesthetic Medical International Hldngs Group Ltd Sponsored ADR $15.9M — (loss-making) 8.3× +25,427.42% (above 0%: growing) n/m −206.36% (below 0%: shrinking) 42.70% (1.24%) Compare
CCM Concord Medical Services Holdings Limited $10.5M — (loss-making) — (loss-making) +37.65% (above 0%: growing) n/m −281.45% (below 0%: shrinking) (13.15%) 0.00% Compare
AMS American Shared Hospital Services $8.4M — (loss-making) 1.8× +19.22% (above 0%: growing) n/m +195.82% (above 0%: growing) 17.00% (7.22%) Compare
CANOQ Cano Health, Inc. $6.6M — (loss-making) — −21.05% (below 0%: shrinking) n/m −43.68% (below 0%: shrinking) 100.00% (16.23%) Compare
MODVQ ModivCare Inc. $6.2M — (loss-making) — (loss-making) −3.18% (below 0%: shrinking) n/m −3,767.70% (below 0%: shrinking) 14.06% (1.78%)
BMGL Basel Medical Group Ltd $6.2M — — — — — — — Compare
RHEP Adcare Health Systems Inc $5.2M 0.6× — (loss-making) +143.03% (above 0%: growing) n/m +224.45% (above 0%: growing) 31.50% (0.88%) Compare
NIVF NewGenIvf Group Limited $2.3M — — — — — — — Compare
Median of peers $7.5M — — +28.44% — −87.98% 31.01% (4.23%)

All 55 Medical Care Facilities stocks →

ModivCare Inc. (MODVQ) key facts

  • Strength: ModivCare Inc.’s revenue for fiscal 2024 (year ended December 2024) was $2.8 billion, up 1.32% from fiscal 2023.
  • ModivCare Inc. (MODVQ) is a Medical Care Facilities company in the Healthcare sector.
  • As of April 1, 2026, MODVQ traded at $0.02, a market capitalization of $6.2 million.
  • Return on equity was −342.0% and debt-to-equity -0.13.
  • Its Piotroski F-score is 3 out of 9 and its Altman Z-score is 1.28 (distress zone) for fiscal 2024.

Source: company filings (standardised) and stockrow calculations.

ModivCare Inc. (MODVQ) Latest News

No news at this impact. Lower the threshold for more.
stockrow.com/MODVQ · Data as of Sep 30, 2025 · For information only; not investment advice. · © 2026 stockrow.com